Hormone Receptor Negative Breast Carcinoma
8 clinical trials · Condition
◉ Watch Hormone Receptor Negative Breast Carcinoma
| Record | Firm | Date |
|---|---|---|
| ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer (NCT04602117) | QuantumLeap Healthcare Collaborative | 2021-07-28 |
Track Hormone Receptor Negative Breast Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.